RXL:NYE-ProShares Ultra Health Care (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 108.3453

Change

+0.20 (+0.18)%

Market Cap

N/A

Volume

2.95K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

+1.47 (+4.17%)

USD 11.38B
QLD ProShares Ultra QQQ

+2.33 (+2.38%)

USD 7.32B
FNGU MicroSectors FANG+ Index 3X Le..

+22.98 (+5.73%)

USD 5.28B
SSO ProShares Ultra S&P500

+1.54 (+1.75%)

USD 5.17B
UPRO ProShares UltraPro S&P500

+2.18 (+2.62%)

USD 4.05B
TECL Direxion Daily Technology Bull..

+2.71 (+3.23%)

USD 3.22B
YINN Direxion Daily FTSE China Bull..

+5.09 (+10.89%)

USD 1.83B
USD ProShares Ultra Semiconductors

+4.19 (+3.50%)

USD 1.18B
LABU Direxion Daily S&P Biotech Bul..

+2.94 (+2.45%)

USD 0.94B
DPST Direxion Daily Regional Banks ..

+5.29 (+5.89%)

USD 0.80B

ETFs Containing RXL

KGHG 4.13 % 0.00 %

N/A

N/A
IEUS iShares MSCI Europe Small.. 0.00 % 0.40 %

+0.59 (+0%)

USD 0.10B
SCZ iShares MSCI EAFE Small-C.. 0.00 % 0.39 %

+0.59 (+0%)

USD 9.37B
LGWU:F Lyxor Index Fund - Lyxor .. 0.00 % 0.00 %

+5.70 (+0%)

N/A
ZPRX:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

+0.76 (+0%)

USD 0.25B
ZPRX:XETRA SPDR® MSCI Europe Small .. 0.00 % 0.00 %

+0.46 (+0%)

USD 0.17B
1388:TSE 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.54% 45% F 76% C+
Dividend Return 0.85% 39% F 14% F
Total Return 19.38% 44% F 73% C
Trailing 12 Months  
Capital Gain 28.75% 18% F 71% C-
Dividend Return 1.12% 22% F 13% F
Total Return 29.87% 15% F 66% D+
Trailing 5 Years  
Capital Gain 120.72% 77% C+ 87% B+
Dividend Return 2.98% 44% F 8% B-
Total Return 123.69% 76% C+ 87% B+
Average Annual (5 Year Horizon)  
Capital Gain 15.49% N/A N/A 79% B-
Dividend Return 15.71% N/A N/A 75% C
Total Return 0.22% N/A N/A 6% D-
Risk Return Profile  
Volatility (Standard Deviation) 27.14% N/A N/A 38% F
Risk Adjusted Return 57.88% N/A N/A 74% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike